Anti-programmed cell death-1 therapy in nonmelanoma skin cancer.

Winkler, J K; Schneiderbauer, R; Bender, C; Sedlaczek, O; Fröhling, S; Penzel, R; Enk, A; Hassel, J C

Winkler, J K; Schneiderbauer, R; Bender, C; Sedlaczek, O; Fröhling, S; Penzel, R; Enk, A; Hassel, J C.

Afiliação

Winkler JK; Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
Schneiderbauer R; Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
Bender C; Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
Sedlaczek O; National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Department of Diagnostic Radiology, University Hospital Heidelberg, Heidelberg, Germany.
Fröhling S; National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Department of Translational Oncology, Heidelberg, Germany.
Penzel R; Section for Personalized Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Enk A; Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Hassel JC; Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.

Br J Dermatol ; 176(2): 498-502, 2017 02.

Article em En | MEDLINE | ID: mdl-27061826

Assuntos

Anticorpos Monoclonais Humanizados/uso terapêutico; Antineoplásicos/uso terapêutico; Carcinoma Basocelular/tratamento farmacológico; Carcinoma de Células Escamosas/tratamento farmacológico; Receptor de Morte Celular Programada 1/antagonistas & inibidores; Neoplasias Cutâneas/tratamento farmacológico; Idoso; Neoplasias da Orelha/tratamento farmacológico; Neoplasias Faciais/tratamento farmacológico; Feminino; Humanos; Neoplasias Pulmonares/tratamento farmacológico; Neoplasias Pulmonares/secundário; Pessoa de Meia-Idade; Receptor de Morte Celular Programada 1/imunologia; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Basocelular / Carcinoma de Células Escamosas / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Br J Dermatol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google